ZSCAN30

Chr 18

zinc finger and SCAN domain containing 30

Also known as: ZNF-WYM, ZNF397OS, ZNF917

The protein functions as a DNA-binding transcription factor that regulates gene expression by RNA polymerase II in the nucleus. Mutations in this gene cause autosomal dominant neurodevelopmental disorders with intellectual disability, developmental delay, and behavioral abnormalities. The gene shows very low constraint against loss-of-function variants, suggesting tolerance to such mutations.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
0
Pubs (1 yr)
45
P/LP submissions
0%
P/LP missense
1.43
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryZSCAN30
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
43 unique Pathogenic / Likely Pathogenic· 68 VUS of 122 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.43LOEUF
pLI 0.000
Z-score 0.11
OE 0.97 (0.681.43)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.07Z-score
OE missense 0.99 (0.891.09)
256 obs / 259.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.97 (0.681.43)
00.351.4
Missense OE0.99 (0.891.09)
00.61.4
Synonymous OE0.87
01.21.6
LoF obs/exp: 19 / 19.5Missense obs/exp: 256 / 259.3Syn Z: 0.99
DN
0.78top 25%
GOF
0.7028th %ile
LOF
0.3357th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

122 submitted variants in ClinVar

Classification Summary

Pathogenic40
Likely Pathogenic3
VUS68
Likely Benign6
40
Pathogenic
3
Likely Pathogenic
68
VUS
6
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
40
0
40
Likely Pathogenic
0
0
3
0
3
VUS
0
67
1
0
68
Likely Benign
0
5
1
0
6
Benign
0
0
0
0
0
Total072450117

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ZSCAN30 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found